Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology | Family Medicine
Idiopathic Membranous Nephropathy Clinical Trials
A listing of Idiopathic Membranous Nephropathy medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Alabama
University of Alabama - Birmingham
Birmingham Alabama 35294
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
California
University of California, Los Angeles
Los Angeles California 90025
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Stanford University Medical Center
Palo Alto California 94304
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Capital Nephrology Medical Group
Sacramento California 95825
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
District of Columbia
The George Washington University Medical Faculty Associates
Washington District of Columbia 20037
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Florida
University of Florida Health Science Center of Jacksonville
Jacksonville Florida 32209
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Georgia
Emory University Hospital
Atlanta Georgia 30322
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Kidney Care Associates, LLC
Augusta Georgia 30901
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Michigan
University of Michigan
Ann Arbor Michigan 48109
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Minnesota
Mayo Clinic
Rochester Minnesota 55905
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Nevada
Sierra Nevada Nephrology Consultants
Reno Nevada 89502
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
New York
Columbia Presbyterian Hospital
New York New York 10032
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
North Carolina
GSK Investigational Site
Chapel Hill North Carolina 27599
A clinical research study of Belimumab 10 mg and Placebo for the treatment of Glomerulonephritis, Membranous
University of North Carolina
Chapel Hill North Carolina 27599
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Duke University Medical Center
Durham North Carolina 27705
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
East Carolina University - Nephrology
Greenville North Carolina 27834
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Nephrology Associates, PLLC
Winston-Salem North Carolina 27103
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Ohio
Metrohealth Medical Center
Cleveland Ohio 44109
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Ohio State University Medical Center
Columbus Ohio 43210
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Pennsylvania
Nephrology Research Consortium
Bethlehem Pennsylvania 18017
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Rhode Island
Rhode Island Hospital
Providence Rhode Island 02903
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
South Carolina
Medical University of South Carolina
Charleston South Carolina 29425
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Tennessee
Southeast Renal Research Institute
Chattanooga Tennessee 37404
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Texas
Baylor College of Medicine - Renal Section
Houston Texas 77030
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Texas Tech University Health Sciences Center
Lubbock Texas 79430
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Wisconsin
Zablocki VAMC
Milwaukee Wisconsin 53295
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Australia
GSK Investigational Site
New Lambton New South Wales 2305
A clinical research study of Belimumab 10 mg and Placebo for the treatment of Glomerulonephritis, Membranous
Canada
University Health Network - Toronto General Hospital
Toronto Ontario M5G 2N2
A clinical trial to evaluate treatments using Repository Corticotropin Injection and Placebo for patients with Proteinuria or Idiopathic Membranous Nephropathy
Italy
GSK Investigational Site
Lecco Lombardia 23900
A clinical research study of Belimumab 10 mg and Placebo for the treatment of Glomerulonephritis, Membranous
Korea, Republic of
Dong-A University Medical Center
Busan 602-715
Patients are needed to participate in a clinical research study of Mycophenolate mofetil, low dose steroid and Cyclosporin, low dose steroid to evaluate Glomerulonephritis, Membranous
Inje University Haeundae Paik Hospital
Busan
Patients are needed to participate in a clinical research study of Mycophenolate mofetil, low dose steroid and Cyclosporin, low dose steroid to evaluate Glomerulonephritis, Membranous
Yeungnam University Medical Center
Daegu 705-717
Patients are needed to participate in a clinical research study of Mycophenolate mofetil, low dose steroid and Cyclosporin, low dose steroid to evaluate Glomerulonephritis, Membranous
Daegu Fatima Hospital
Daegu 701-600
Patients are needed to participate in a clinical research study of Mycophenolate mofetil, low dose steroid and Cyclosporin, low dose steroid to evaluate Glomerulonephritis, Membranous
Kyungpook National University Hospital
Daegu 700-721
Patients are needed to participate in a clinical research study of Mycophenolate mofetil, low dose steroid and Cyclosporin, low dose steroid to evaluate Glomerulonephritis, Membranous
View More »
Yonsei University Hospital
Seoul 120-752
Patients are needed to participate in a clinical research study of Mycophenolate mofetil, low dose steroid and Cyclosporin, low dose steroid to evaluate Glomerulonephritis, Membranous
Seoul National University Hospital
Seoul 110-799
Patients are needed to participate in a clinical research study of Mycophenolate mofetil, low dose steroid and Cyclosporin, low dose steroid to evaluate Glomerulonephritis, Membranous
Boramae Medical Center
Seoul 156-707
Patients are needed to participate in a clinical research study of Mycophenolate mofetil, low dose steroid and Cyclosporin, low dose steroid to evaluate Glomerulonephritis, Membranous
Ulsan University Hospital
Ulsan 682-714
Patients are needed to participate in a clinical research study of Mycophenolate mofetil, low dose steroid and Cyclosporin, low dose steroid to evaluate Glomerulonephritis, Membranous
Netherlands
GSK Investigational Site
Nijmegen 6525 GA
A clinical research study of Belimumab 10 mg and Placebo for the treatment of Glomerulonephritis, Membranous
Spain
GSK Investigational Site
Valencia 46017
A clinical research study of Belimumab 10 mg and Placebo for the treatment of Glomerulonephritis, Membranous